Area of expertise: Biochemistry (mode of action and resistance)
Anthony Maxwell
Group Leader
John Innes Centre
more
Stefan Miller
Scientific Advisor
Lysando
more
Francois Moreau
Chief Scientific Officer
Tamrisa Innovation
more
Rolf Müller
Managing Director
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
more
Alex O’Neill
Professor
University of Leeds
more
Malcolm Page
Formerly Roche, Switzerland
more
David Pompliano
Founding Chief Scientific Officer
Lodo Therapeutics
more
Katie Prosen
Senior Associate
Venatorx Pharmaceuticals
more
Hans-Georg Sahl
Emeritus Professor
University of Bonn
more
William Shafer
Professor of Microbiology and Immunology
Emory University School of Medicine
more